Article

Clinical course impacts early kinetics and long-term magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond one year after infection

2021-08-13

Abstract excerpt

<h4>Background</h4> Understanding the determinants of long-term immune responses to SARS-CoV-2 and the concurrent impact of vaccination and emerging variants of concern will guide optimal strategies to achieve global protection against the COVID-19 pandemic. <h4>Methods</h4> A prospective cohort of 332 COVID-19 patients was followed beyond one year. Plasma neutralizing activity was evaluated using HIV-based report...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c7a49a45-d687-5577-aac2-6a5c221fefb4
DOI: 10.1101/2021.08.12.21261921

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical course impacts early kinetics and long-term magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond one year after infectionDOI 10.1101/2021.08.12.21261921Read

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccinationSemantic proximity Read

Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalizationSemantic proximity Read

Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsSemantic proximity Read

Persistence of neutralizing antibodies a year after SARS-CoV-2 infectionSemantic proximity Read

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern.Semantic proximity Read

Antibody Responses In Non-Severe SARS-CoV-2 Infections Are Driven By CD4+ T cells and AgeSemantic proximity Read

Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infectionSemantic proximity Read

SARS-CoV-2 Humoral Immune Responses in Convalescent Individuals Over 12 Months Reveal Severity-Dependent Antibody DynamicsSemantic proximity Read

Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 InfectionSemantic proximity Read

Early functional maturation of anti-Spike antibodies predicts SARS-CoV-2 RNA clearance in mild infectionSemantic proximity Read

Differential antibody dynamics to SARS-CoV-2 infection and vaccinationSemantic proximity Read

Correlates of protection against SARS-CoV-2 shedding in a controlled human infection study in immune-experienced participantsSemantic proximity Read